Published in Clin Pediatr (Phila) on May 01, 1977
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol (2008) 1.21
Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns. Arch Dis Child Fetal Neonatal Ed (2004) 0.82
Pregnancy and drug addiction--long-term consequences. J R Soc Med (1991) 0.77
Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies. Can Fam Physician (1991) 0.75
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med (2001) 6.01
Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet (1986) 4.54
Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA (1986) 2.30
Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics (1986) 2.09
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol (1977) 1.73
Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.72
Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics (1995) 1.58
Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr (1990) 1.52
Infection in infants and children. Am J Dis Child (1977) 1.45
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics (2001) 1.33
Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol (1987) 1.28
Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr (1995) 1.27
Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child (1989) 1.13
Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. Hum Pathol (1985) 1.10
Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay. Clin Diagn Lab Immunol (1995) 1.09
Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. Arch Pathol Lab Med (1985) 1.07
Pathology of suspected acquired immune deficiency syndrome in children: a study of eight cases. Pediatr Pathol (1984) 1.07
Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Its correction. Am J Dis Child (1979) 0.97
Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progression. Pediatrics (1988) 0.96
Thymus biopsy in children with acquired immunodeficiency syndrome. Arch Pathol Lab Med (1986) 0.95
Pulmonary lesions in children with the acquired immunodeficiency syndrome: a reappraisal based on data in additional cases and follow-up study of previously reported cases. Hum Pathol (1986) 0.95
Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy. Ann Neurol (1987) 0.94
Complications of peritonsillar abscess due to Fusobacterium necrophorum. Pediatrics (1976) 0.93
Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.93
Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr (2000) 0.92
Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome. Cancer (1987) 0.89
Effects of antimicrobials on host defence mechanism. J Antimicrob Chemother (1984) 0.89
Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr (1988) 0.89
Conduction system in children with acquired immunodeficiency syndrome. Chest (1989) 0.89
Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product. J Allergy Clin Immunol (1998) 0.89
Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome. Pediatr Infect Dis (1985) 0.87
Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome. Pediatrics (1988) 0.87
Lead poisoning--one approach to a problem that won't go away. Environ Health Perspect (1997) 0.87
Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases. Pediatr Res (1987) 0.84
Zinc and immunocompetence in the elderly: baseline data on zinc nutriture and immunity in unsupplemented subjects. Am J Clin Nutr (1987) 0.84
Effects of antibiotics on polymorphonuclear leukocyte chemiluminescence and chemotaxis. J Antimicrob Chemother (1983) 0.81
Severe gastrointestinal involvement in children with the acquired immunodeficiency syndrome. J Pediatr Gastroenterol Nutr (1988) 0.80
Dilated cardiomyopathy in children with acquired immunodeficiency syndrome: a pathologic study of five cases. Hum Pathol (1988) 0.80
Morphologic findings in children with acquired immune deficiency syndrome: pathogenesis and clinical implications. Pediatr Pathol (1990) 0.79
I.v. immune globulin: efficacy and safety. Hosp Pract (Off Ed) (1987) 0.77
Release of some trace metals from disposable coils during hemodialysis. Am J Clin Nutr (1982) 0.77
Regarding dietary calcium to reduce lead toxicity. Nutr Rev (2001) 0.76
Pathology of opportunistic infections in children with acquired immune deficiency syndrome. Pediatr Pathol (1986) 0.76
Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol (1988) 0.75
In search of the Holy Grail. Arch Pediatr Adolesc Med (1996) 0.75
Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection. Cutis (1995) 0.75
Neoplastic diseases in children with acquired immunodeficiency syndrome. Prog AIDS Pathol (1990) 0.75
Who cares for the human immunodeficiency virus-infected child? Pediatrics (1989) 0.75
Radiographic patterns of PLH/LIP in HIV positive children. Pediatr Radiol (1993) 0.75
Acrodermatitis enteropathica, immunodeficiency, and zinc. Cutis (1978) 0.75
Children with HIV infection. Dilemmas in management. Caring (1989) 0.75
Juvenile papilloma of the larynx. Am J Dis Child (1971) 0.75
Acquired immune deficiency syndrome in children. Pediatr Infect Dis (1983) 0.75
Fecal incontinence with myocardial infarction. N Engl J Med (1979) 0.75
Elevated plasma zinc concentrations in renal dialysis patients. Am J Clin Nutr (1980) 0.75
Managing early HIV infection. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin (1994) 0.75
Blood product acquired HIV infection in children. Pediatr Ann (1988) 0.75
Pregnancy complicated by heroin addiction. Obstet Gynecol (1975) 0.75
Congenital acquired immunodeficiency syndrome and congenital toxoplasmosis: pathologic support for a chronology of events. J Perinatol (1988) 0.75
Cellulitis. Cutis (1999) 0.75
The effects of acute infection on blood lead, copper, and zinc levels in children. Health Lab Sci (1975) 0.75
Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group. Pediatr Infect Dis J (1997) 0.75
Letter: Not all children are magpies. Pediatrics (1975) 0.75
Enhancement of nitroblue tetrazolium dye reduction by leucocytes exposed to a factor released from sensitised lymphocytes. Aust J Exp Biol Med Sci (1979) 0.75